These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6127087)

  • 1. Pharmacokinetics of intravenous camazepam in dogs.
    Legheand J; Cuisinaud G; Bernard N; Riotte M; Sassard J
    Arzneimittelforschung; 1982; 32(7):752-6. PubMed ID: 6127087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction time to acoustic or visual stimuli after administration of camazepam and diazepam in man.
    Tallone G; Ghirardi P; Bianchi MC; Ravaccia F; Bruni G; Loreti P
    Arzneimittelforschung; 1980; 30(6):1021-4. PubMed ID: 6106497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amixetrine in the dog. Relation of dose-to-plasma concentration.
    Constantin M; Pognat JF
    Arzneimittelforschung; 1978; 28(4):646-51. PubMed ID: 581941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species differences in the disposition and metabolism of camazepam.
    Morino A; Nakamura A; Nakanishi K; Tatewaki N; Sugiyama M
    Xenobiotica; 1985 Dec; 15(12):1033-43. PubMed ID: 2868575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pharmacokinetic and pharmacodynamic comparison of two different formulations of temazepam.
    Mattila MJ; Mattila M; Tuomainen P
    Med Biol; 1985; 63(1):21-7. PubMed ID: 2860283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic fate of camazepam in rats.
    Nakamura A; Tatewaki N; Morino A; Sugiyama M
    Xenobiotica; 1986 Dec; 16(12):1079-89. PubMed ID: 2879390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vinpocetine (Cavinton) in dog.
    Polgár M; Vereczkey L
    Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of abouthiouzine: a novel antihyperthyroid drug.
    Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
    Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of pinazepam in healthy volunteers.
    Pacifici GM; Placidi GF; Fornaro P; Gomeni R
    Int J Clin Pharmacol Res; 1983; 3(5):331-7. PubMed ID: 6147314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of cefovecin in dogs.
    Stegemann MR; Sherington J; Blanchflower S
    J Vet Pharmacol Ther; 2006 Dec; 29(6):501-11. PubMed ID: 17083454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of camazepam in rats and mice.
    Marcucci F; Mussini E; Cotellessa L; Ghirardi P; Parenti M; Riva R; Salva P
    J Pharm Sci; 1978 Oct; 67(10):1470-1. PubMed ID: 29957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenous and intramuscular methohexitone in dogs.
    Pinaud M; Meignier M; Kergueris MF; Le Normand Y; Lasserre MP; Souron R; Larousse C
    Eur J Anaesthesiol; 1984 Mar; 1(1):55-62. PubMed ID: 6536507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vincamine concentrations in plasma and cerebrospinal fluid in patients following intravenous infusion (author's transl)].
    Siegers CP; Heiss WD; Kohlmeyer K
    Arzneimittelforschung; 1977; 27(6a):1274-7. PubMed ID: 578452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.